Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg M Lauer

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
Gut|June 21, 2015
The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine designAnnette von Delft, Isla S Humphreys, Anthony Brown, et al.
Pathogens & Immunity|March 16, 2018
ADCC-Mediated CD56<sup>DIM</sup> NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV InfectionWen-Han Yu, Cormac Cosgrove, Christoph T Berger, et al.
Plos One|August 23, 2014
Chronic HCV infection affects the NK cell phenotype in the blood more than in the liverCormac Cosgrove, Christoph T Berger, Daniela C Kroy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Acute hepatitis C virus infection in incarcerated injection drug usersBarbara H McGovern, Alysse Wurcel, Arthur Y Kim, et al.
The Journal of Infectious Diseases|February 10, 2009
Temporal dynamics of a predominant protease inhibitor-resistance mutation in a treatment-naive, hepatitis C virus-infected individualArthur Y Kim, Joerg Timm, Brian E Nolan, et al.
Vaccine|November 14, 2006
Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteinsAurelia A Haller, Georg M Lauer, Thomas H King, et al.
Science Advances|January 8, 2019
Genetic and structural insights into broad neutralization of hepatitis C virus by human V<sub>H</sub>1-69 antibodiesNetanel Tzarum, Erick Giang, Leopold Kong, et al.
Journal of Virology|February 28, 2002
Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent virusesGeorg M Lauer, Tam N Nguyen, Cheryl L Day, et al.
Journal of Virology|May 22, 2002
Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificitiesGeorg M Lauer, Kei Ouchi, Raymond T Chung, et al.
JCI Insight|December 14, 2021
Peripheral blood iNKT cell activation correlates with liver damage during acute hepatitis CTina Senff, Christopher Menne, Christine Cosmovici, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Gut|June 21, 2015
The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine designAnnette von Delft, Isla S Humphreys, Anthony Brown, et al.
Pathogens & Immunity|March 16, 2018
ADCC-Mediated CD56<sup>DIM</sup> NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV InfectionWen-Han Yu, Cormac Cosgrove, Christoph T Berger, et al.
Plos One|August 23, 2014
Chronic HCV infection affects the NK cell phenotype in the blood more than in the liverCormac Cosgrove, Christoph T Berger, Daniela C Kroy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Acute hepatitis C virus infection in incarcerated injection drug usersBarbara H McGovern, Alysse Wurcel, Arthur Y Kim, et al.
The Journal of Infectious Diseases|February 10, 2009
Temporal dynamics of a predominant protease inhibitor-resistance mutation in a treatment-naive, hepatitis C virus-infected individualArthur Y Kim, Joerg Timm, Brian E Nolan, et al.
Vaccine|November 14, 2006
Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteinsAurelia A Haller, Georg M Lauer, Thomas H King, et al.
Science Advances|January 8, 2019
Genetic and structural insights into broad neutralization of hepatitis C virus by human V<sub>H</sub>1-69 antibodiesNetanel Tzarum, Erick Giang, Leopold Kong, et al.
Journal of Virology|February 28, 2002
Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent virusesGeorg M Lauer, Tam N Nguyen, Cheryl L Day, et al.
Journal of Virology|May 22, 2002
Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificitiesGeorg M Lauer, Kei Ouchi, Raymond T Chung, et al.
JCI Insight|December 14, 2021
Peripheral blood iNKT cell activation correlates with liver damage during acute hepatitis CTina Senff, Christopher Menne, Christine Cosmovici, et al.
Pageof 11